|
|
||||||||
From the Department of Medicine, Case-Western Reserve University School of Medicine and Cleveland Metropolitan General Hospital, Cleveland, Ohio 44109
Abstract
The reaction of C-reactive protein (CRP) with C-polysaccharide and the choline phosphatides, lecithin and sphingomyelin, previously shown to induce consumption of human complement, failed to effect consumption of guinea pig complement except in the presence of a thermolabile human serum factor. The amount of guinea pig complement consumed by CRP complexes was dependent on optimal proportions of CRP, C-polysaccharide, or phosphatide, and human serum cofactor in the reaction mixture.
In subsequent experiments, the serum factor was found associated with human Clq: On DEAE-cellulose chromatography of euglobulin, cofactor activity was associated with the first protein peak and was further enhanced by supplementation with two other chromatographic fractions, consistent with a trimolecular complex of Clq, r, and s. On gradient ultracentrifugation, cofactor activity corresponded to a value of 16.9S in the presence of Ca++ and 12.9S in the presence of EDTA. On filtration through Sephadex G-200 in the presence of Ca++, cofactor and C1 activities were concentrated in the excluded peak. In the presence of EDTA, cofactor activity was also demonstrable in the excluded peak although at lower levels. Fractions with cofactor activity consistently gave precipitin reaction for Clq.
Depletion of fresh human serum of Clq by treatment with washed immune precipitate or with aggregated human
-globulin resulted in complete loss of cofactor activity. Alternatively, addition of purified human Clq provided the cofactor activity for consumption of guinea pig complement.
These combined data indicated that the consumption of guinea pig complement by CRP complexes required participation of human Clq, and that these complexes presumably do not interact with guinea pig Clq.
Footnotes
1 This work was presented in part at the annual meeting of the American Association of Immunologists (Fed. Proc. 30: 471, 1971) and at the First International Congress of Immunology, Washington, D. C., 1971.
This work was supported by Grant H-3726 from the United States Public Health Service.
2 Research Career Awardee, United States Public Health Service (K6-HE-4576).
This article has been cited by other articles:
![]() |
P. T. Johnson, K. E. Betts, M. J. Radeke, G. S. Hageman, D. H. Anderson, and L. V. Johnson Individuals homozygous for the age-related macular degeneration risk-conferring variant of complement factor H have elevated levels of CRP in the choroid PNAS, November 14, 2006; 103(46): 17456 - 17461. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Paffen and M. P.M. deMaat C-reactive protein in atherosclerosis: A causal factor? Cardiovasc Res, July 1, 2006; 71(1): 30 - 39. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. V. Suresh, S. K. Singh, D. A. Ferguson Jr., and A. Agrawal Role of the Property of C-Reactive Protein to Activate the Classical Pathway of Complement in Protecting Mice from Pneumococcal Infection J. Immunol., April 1, 2006; 176(7): 4369 - 4374. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. D. G. McGrath, M. C. Brouwer, G. J. Arlaud, M. R. Daha, C. E. Hack, and A. Roos Evidence That Complement Protein C1q Interacts with C-Reactive Protein through Its Globular Head Region. J. Immunol., March 1, 2006; 176(5): 2950 - 2957. [Abstract] [Full Text] [PDF] |
||||
![]() |
P A J Krijnen, C Ciurana, T Cramer, T Hazes, C J L M Meijer, C A Visser, H W M Niessen, and C E Hack IgM colocalises with complement and C reactive protein in infarcted human myocardium J. Clin. Pathol., April 1, 2005; 58(4): 382 - 388. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Paffen, H. L. Vos, and R. M. Bertina C-Reactive Protein Does Not Directly Induce Tissue Factor in Human Monocytes Arterioscler. Thromb. Vasc. Biol., May 1, 2004; 24(5): 975 - 981. [Abstract] [Full Text] |
||||
![]() |
G.M. Hirschfield and M.B. Pepys C-reactive protein and cardiovascular disease: new insights from an old molecule QJM, November 1, 2003; 96(11): 793 - 807. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Nijmeijer, W. K. Lagrand, Y. T. P. Lubbers, C. A. Visser, C. J. L. M. Meijer, H. W. M. Niessen, and C. E. Hack C-Reactive Protein Activates Complement in Infarcted Human Myocardium Am. J. Pathol., July 1, 2003; 163(1): 269 - 275. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Gould and J. N. Weiser Expression of C-Reactive Protein in the Human Respiratory Tract Infect. Immun., March 1, 2001; 69(3): 1747 - 1754. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. J. Culley, K. B. Bodman-Smith, M. A. J. Ferguson, A. V. Nikolaev, N. Shantilal, and J. G. Raynes C-reactive protein binds to phosphorylated carbohydrates Glycobiology, January 1, 2000; 10(1): 59 - 65. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Griselli, J. Herbert, W.L. Hutchinson, K.M. Taylor, M. Sohail, T. Krausz, and M.B. Pepys C-reactive Protein and Complement Are Important Mediators of Tissue Damage in Acute Myocardial Infarction J. Exp. Med., December 20, 1999; 190(12): 1733 - 1740. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Jarva, T. S. Jokiranta, J. Hellwage, P. F. Zipfel, and S. Meri Regulation of Complement Activation by C-Reactive Protein: Targeting the Complement Inhibitory Activity of Factor H by an Interaction with Short Consensus Repeat Domains 7 and 8-11 J. Immunol., October 1, 1999; 163(7): 3957 - 3962. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. O. Kim, S. Romero-Steiner, U. B. S. Sorensen, J. Blom, M. Carvalho, S. Barnard, G. Carlone, and J. N. Weiser Relationship between Cell Surface Carbohydrates and Intrastrain Variation on Opsonophagocytosis of Streptococcus pneumoniae Infect. Immun., May 1, 1999; 67(5): 2327 - 2333. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. N. Weiser, N. Pan, K. L. McGowan, D. Musher, A. Martin, and J. Richards Phosphorylcholine on the Lipopolysaccharide of Haemophilus influenzae Contributes to Persistence in the Respiratory Tract and Sensitivity to Serum Killing Mediated by C-reactive Protein J. Exp. Med., February 16, 1998; 187(4): 631 - 640. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |